Bio Marketing

BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China

In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...

 September 14, 2023 | News

Companies Embracing Rebranding in Biotech, Life Sciences, and Biopharma

Companies in these sectors often find it essential to adapt to changing market dynamics, emerging technologies, and shifting consumer expectations. One eff...

 September 07, 2023 | Analysis

iotaSciences and Quantum Design China Enter into Distribution Agreement

iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Des...

 September 07, 2023 | News

Daewoong Pharmaceutical Introduces 'Fexuprazan' with Global Export to the Philippines

 Daewoong Pharmaceutical (CEO Jeon Seng-ho, Lee Chang-jae) announced that 'Fuxuprazan' is officially launched in the Philippines o...

 August 17, 2023 | News

OmiGroup Unveils New Brand Identity and The Pioneer Mission for Japan Digital Healthcare

 OmiGroup, a prominent brand, has recently undergone a significant transformation, introducing a refreshed logo and redefined core values. Howeve...

 June 22, 2023 | News

Viseven and SpotMe Join Forces for Digital Transformation

Driving Success in Pharma Communication The partnership between Viseven and SpotMe creates a unique point of view on the HCP engagement and B2B event orga...

 June 21, 2023 | News

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

 May 31, 2023 | News

Eppendorf Group inaugurates new Distribution Center in the USA

New distribution center officially opened in Enfield, Connecticut Targeted strengthening of the supply chain and of the customer focus throughout the Am...

 May 11, 2023 | News

Servier's Tibsovo® approved by European Commission for IDH1-mutated AML and Cholangiocarcinoma

Marketing Authorization granted for Tibsovo® as the first and only approved IDH1 targeted therapy in Europe IDH1-mutate...

 May 11, 2023 | Regulatory

PerkinElmer Unveils Revvity, its Innovative Science-Based Solutions Company for Life Sciences and Diagnostics

 Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...

 May 09, 2023 | News

Hasten Biopharma Acquires Chinese Commercial Rights for Roche's Rocephin® Antibiotic.

Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-...

 May 05, 2023 | News

Asieris subsidiary obtains "Drug Distribution License" for commercialization strategy.

Hainan Asieris' acquisition of the Drug Distribution Licence is a critical step towards improvement in the quality of drug circulation services, standardiz...

 April 11, 2023 | News

Pharma marketing future and present: AI & Modular Content in APAC focus

At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...

 March 31, 2023 | News

Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine

Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...

 March 28, 2023 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in